机构地区:[1]中国中医科学院广安门医院心血管科,北京100053
出 处:《中国循证心血管医学杂志》2025年第1期1-7,共7页Chinese Journal of Evidence-Based Cardiovascular Medicine
基 金:国家自然科学基金重点项目(82230124);国家中医药管理局中医药创新团队与人才支持计划项目(ZYYCXTD-D-202210);中医药传承与创新“百千万”人才工程-岐黄工程首席科学家项目(0201000401)。
摘 要:目的心肌梗死后心力衰竭(MI-HF)是一类常见的心血管疾病。本研究旨在初步探讨MI-HF领域的研究现状与发展趋势,为临床及科研提供可参考的思路与方法。方法检索2012~2022年间Web of Science Core Collection数据库的SCI-expanded数据集中与MI-HF相关的出版物,运用VOSviewer,R-bibliometrix进行文献计量与可视化分析,包括发文量、国家、机构、作者、期刊、参考文献和关键词。结果过去10年间共发表了10929篇本领域文章,共有58357名作者参与研究,来自120个不同国家地区的10437个研究机构,这些研究成果发表在1446种不同的期刊上。美国为发文量最多的国家,发文量最多的机构是哈佛大学医学院,数量最多的作者为丹麦哥本哈根大学的Kober Lars。Plos One是发文量最多的期刊,而被引次数最高的是Circulation。本领域近10年的研究热点主要涉及死亡率、心脏重塑以及预后等,最近2年集中在孟德尔随机化、达格列净、沙库巴曲/缬沙坦、COVID-19和机器学习等。结论本研究揭示了MI-HF研究领域相关文献的整体表现。患者的预后与心脏重塑等是近10年来的研究热点,患者的死亡率、再住院率仍是目前亟待解决的临床难题。围绕着MI-HF的心脏重塑、细胞凋亡和炎症等机制研究以及患者病死率等临床预后研究可能是本领域未来的研究趋势。此外,超声心动图、心脏核磁技术逐渐成为评价药物疗效和阐述相关机制的重要方法之一。Objective Post-myocardial infarction heart failure(MI-HF)is a prevalent cardiovascular disease.The study aims to preliminarily explore the current research status and development trends in the field of MI-HF,providing reference ideas and methods for clinical and scientific research.Methods Publications related to MI-HF from 2012~2022 in the Web of Science Core Collection's SCI-expanded dataset were extracted.Bibliometric analysis was executed using VOSviewer and R-bibliometrix,encompassing the number of publications,countries,institutions,authors,journals,cited references,and keywords.Results Within the last decade,10929 publications in the domain were published,involving 58357 authors from 10437 research institutions across 120 countries and regions.These findings appeared in 1446 distinct journals.The united states led in the number of publications,with harvard medical school being the most active institution and Kober,Lars from the university of copenhagen,Denmark,as the leading author.Plos one was the most prolific journal,while Circulation had the highest citation count.Over the past decade,research hotspots mainly centered on mortality,cardiac remodeling,and prognosis.In the recent two years,emphasis shifted to mendelian randomization,dapagliflozin,sacubitril/valsartan,COVID-19,and machine learning.Conclusion The study reveals the overall performance of publications in the MI-HF research field.The clinical prognosis of patients and cardiac remodeling have been research hotspots over the past decade,yet mortality and rehospitalization rates remain urgent clinical challenges.Future research trends in this field may revolve around the mechanisms of cardiac remodeling,apoptosis,and inflammation,as well as clinical prognosis studies on patient mortality rates.Additionally,echocardiography and cardiac magnetic resonance technology are becoming important methods for evaluating drug efficacy and elucidating related mechanisms.
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...